---
layout: post
title: "Guidance Documents Related to Coronavirus Disease 2019; Availability"
date: 2026-02-05 18:57:47 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-01146
original_published: 2022-01-21 00:00:00 +0000
significance: 8.00
---

# Guidance Documents Related to Coronavirus Disease 2019; Availability

**Published:** February 05, 2026 18:57 UTC
**Source:** Federal Register
**Original Published:** January 21, 2022 00:00 UTC
**Document Number:** 2022-01146

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of FDA guidance documents related to the Coronavirus Disease 2019 (COVID-19) public health emergency (PHE). This notice of availability (NOA) is pursuant to the process that FDA announced, in the Federal Register of March 25, 2020, for making available to the public COVID-19-related guidances. The guidances identified in this notice address issues related to the COVID-19 PHE and have been issued in accordance with the process announced in the March 25, 2020, notice. The guidances have been implemented without prior comment, but they remain subject to comment in accordance with the Agency's good guidance practices.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/01/21/2022-01146/guidance-documents-related-to-coronavirus-disease-2019-availability)
- API: https://www.federalregister.gov/api/v1/documents/2022-01146

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
